Food energy efficiency, cannabinoids, and a slow death of the weight loss dogma

Hepatology

Volumn 46, Issue 1, 2007, Pages 12-15

  Neuschwander Tetri, Brent A ^a  

^a Saint Louis University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; DRONABINOL; RIMONABANT;

CALORIE; DEATH; EDITORIAL; FOOD INTAKE; NEUROTRANSMISSION; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ANIMAL FEED; ANIMALS; APPETITE; CANNABINOIDS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; HUMANS; MICE; RECEPTOR, CANNABINOID, CB1; WEIGHT LOSS;

EID: 34547472174     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21821     Document Type: Editorial

References (22)

1. Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active component of hashish. J Am Chem Soc 1964;86:1646-1647.
2. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Hewlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988;34:605-613.
3. Di Marzo V, Petrocellis LD. Plant, synthetic, and endogenous cannabinoids in medicine. Annu Rev Med 2006;57:553-574.
4. Cota D, Tschöp MH, Horvath TL, Levine AS. Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res Brain Res Rev 2006;51:85-107.
5. Moore SA, Nomikos GG, Dickason-Chesterfield AK, Schober DA, Schaus JM, Ying BP, et al. Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc Natl Acad Sci U S A 2005;102: 17852-17857.
6. 2+-dependent and -independent mechanisms. FEBS Lett 1998;429:152-156.
7. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001;410:822-825.
8. Kirkham TC. Endogenous cannabinoids: a new target in the treatment of obesity. Am J Physiol Regul Integr Comp Physiol 2003;284:R343-R344.
9. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 1994;350:240-244.
10. Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S, for the RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005;365:1389-1397.
11. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, for the RIO-North America Study Group. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 2006;295:761-775.
12. Pagotto U, Pasquali R. The role of the endocannabinoid pathway in metabolism and diabetes. Curr Opin Endocrinol Diabetes 2006;13: 171-178.
13. Després J-P, Golay A, Sjöström L, for the Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005;353:2121-2134.
14. Woods SC. The endocannabinoid system: mechanisms behind metabolic homeostasis and imbalance. Am J Med 2007;120:S9-S17.
15. Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand J-P, et al. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 2003;284:R345-353.
16. Cota D, Marsicano G, Tschöp M, Grübler Y, Flachskamm C, Schubert M, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003;112: 423-431.
17. Sipe JC, Waalen J, Gerber A, Beutler E. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int J Obes (Lond) 2005;29:755-759.
18. Jbilo O, Ravinet-Trillou C, Arnone M, Buisson I, Bribes E, Péleraux A, et al. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 2005;19:1567-1569.
19. Liu YL, Connoley IP, Wilson CA, Stock MJ. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice. Int J Obes (Lond) 2005;29:183-187.
20. Gary-Bobo M, Elachouri G, Gallas JF, Janiak P, Marini P, Ravinet Trillou C, et al. Rimonabant reduces obesity-associated hepatic steatosis and metabolic syndrome features in obese Zucker fa/fa rat. HEPATOLOGY 2007;46: 122-129.
21. 1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005;115: 1298-1305.
22. Horvath TL. The unfolding cannabinoid story on energy homeostasis: central or peripheral site of action? Int J Obes (Lond) 2006;(30 Suppl 1):S30-S32.